The Winner is...Trevor Hadley, BS!
The National Lipid Association (NLA) and the Foundation of the NLA are proud to announce the winner of the 2020 Young Investigator Award for outstanding lipid research: Trevor D. Hadley, BS, Baylor College of Medicine, Houston, Texas, for abstract 213 titled:
Genetic Testing for Hypertriglyceridemia--Experience from a single center lipid clinic
Congratulations to Aleesha Shaik, MD, New York, NY, for winning second-place
Denver-area clinical pharmacist assumes role during NLA virtual business meeting
JACKSONVILLE, Fla. — Joseph J. Saseen, PharmD, CLS, FNLA, officially assumed the role of National Lipid Association (NLA) President at the NLA’s annual virtual business meeting on Monday, June 8, 2020 after serving for the past year as President-Elect. He succeeds Houston-based lipidologist Antonio M. Gotto, MD, DPhil, FNLA, who will be the NLA’s Immediate Past President.
Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United States. NEXLIZET™ is an oral, once-daily, fixed-dose combination tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.
.jpg)
.png)
(1).png)
